Skip to main navigation Skip to search Skip to main content

A Randomized, Double-Blind, Placebo Controlled, Parallel Arm, Multicenter, Phase 2 Study To Evaluate The Efficacy And Safety Of Lorundrostat In Subjects With Uncontrolled Hypertension On A Standardized Medication Regimen

Project: Research

Project Details

StatusFinished
Effective start/end date07/10/23 → 05/31/26

Funding

  • Mineralys Therapeutics Limited Liability Corporation: $129,094.36